Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

Similar articles for PubMed (Select 20981137)

1.

Heterogeneity Between Ducts of the Same Nuclear Grade Involved by Duct Carcinoma In Situ (DCIS) of the Breast.

Miller NA, Chapman JA, Qian J, Christens-Barry WA, Fu Y, Yuan Y, Lickley HL, Axelrod DE.

Cancer Inform. 2010 Sep 7;9:209-16.

2.

Ductal carcinoma in situ of the breast (DCIS) with heterogeneity of nuclear grade: prognostic effects of quantitative nuclear assessment.

Chapman JA, Miller NA, Lickley HL, Qian J, Christens-Barry WA, Fu Y, Yuan Y, Axelrod DE.

BMC Cancer. 2007 Sep 10;7:174.

3.

Effect of quantitative nuclear image features on recurrence of Ductal Carcinoma In Situ (DCIS) of the breast.

Axelrod DE, Miller NA, Lickley HL, Qian J, Christens-Barry WA, Yuan Y, Fu Y, Chapman JA.

Cancer Inform. 2008;6:99-109. Epub 2008 Mar 1.

4.

Differences in the pathologic features of ductal carcinoma in situ of the breast based on patient age.

Goldstein NS, Vicini FA, Kestin LL, Thomas M.

Cancer. 2000 Jun 1;88(11):2553-60.

PMID:
10861433
5.

Quantitative nuclear morphometry by image analysis for prediction of recurrence of ductal carcinoma in situ of the breast.

Hoque A, Lippman SM, Boiko IV, Atkinson EN, Sneige N, Sahin A, Weber DM, Risin S, Lagios MD, Schwarting R, Colburn WJ, Dhingra K, Follen M, Kelloff GJ, Boone CW, Hittelman WN.

Cancer Epidemiol Biomarkers Prev. 2001 Mar;10(3):249-59.

7.
8.

Pure ductal carcinoma in situ and in situ component of ductal invasive carcinoma of the breast. A preliminary morphometric study.

Giardina C, Serio G, Lepore G, Lettini T, Dalena AM, Pennella A, D'Eredità G, Valente T, Ricco R.

J Exp Clin Cancer Res. 2003 Jun;22(2):279-88.

PMID:
12866579
9.
10.

p53 missense mutations in microdissected high-grade ductal carcinoma in situ of the breast.

Done SJ, Eskandarian S, Bull S, Redston M, Andrulis IL.

J Natl Cancer Inst. 2001 May 2;93(9):700-4.

11.

Nuclear cytometric changes in breast carcinogenesis.

Mommers EC, Poulin N, Sangulin J, Meijer CJ, Baak JP, van Diest PJ.

J Pathol. 2001 Jan;193(1):33-9.

PMID:
11169513
13.
14.

In situ duct carcinoma of the breast: clinical and histopathologic factors and association with recurrent carcinoma.

Miller NA, Chapman JA, Fish EB, Link MA, Fishell E, Wright B, Lickley HL, McCready DR, Hanna WM.

Breast J. 2001 Sep-Oct;7(5):292-302.

PMID:
11906438
15.
17.

Outcome and prognostic factors for local recurrence in mammographically detected ductal carcinoma in situ of the breast treated with conservative surgery and radiation therapy.

White J, Levine A, Gustafson G, Wimbish K, Ingold J, Pettinga J, Matter R, Martinez A, Vicini F.

Int J Radiat Oncol Biol Phys. 1995 Feb 15;31(4):791-7.

PMID:
7860390
18.

Nuclear grading of breast carcinoma by image analysis. Classification by multivariate and neural network analysis.

Dawson AE, Austin RE Jr, Weinberg DS.

Am J Clin Pathol. 1991 Apr;95(4 Suppl 1):S29-37.

PMID:
2008882
19.

Quantitative study of breast cancer progression: different pathways for various in situ cancers.

Mariuzzi L, Mombello A, Granchelli G, Rucco V, Tarocco E, Frank D, Davis J, Thompson D, Bartels H, Mariuzzi GM, Bartels PH.

Mod Pathol. 2002 Jan;15(1):18-25.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk